Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001233082 | SCV001405662 | pathogenic | Hereditary spastic paraplegia 4 | 2022-09-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 959690). This variant has not been reported in the literature in individuals affected with SPAST-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser101*) in the SPAST gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPAST are known to be pathogenic (PMID: 20932283). |
Institute of Medical Genetics and Applied Genomics, |
RCV001291596 | SCV001480144 | pathogenic | not provided | 2021-02-01 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV001233082 | SCV002579809 | likely pathogenic | Hereditary spastic paraplegia 4 | 2022-03-24 | criteria provided, single submitter | clinical testing |